Sign In
Buy ABT
$90.51
-0.0200 (-0.0221%)
At Close: Jun 24, 2026
Abbott's (ABT) EPD Expansion Continues Despite FX Headwind
12:40pm, Monday, 24'th Jun 2024
Banking on the successful execution of its Branded Generic operating model, Abbott's (ABT) EPD is well-positioned for sustained growth in many of the growing pharmaceutical markets.
Wall Street Analysts Think Abbott (ABT) Is a Good Investment: Is It?
10:35am, Monday, 24'th Jun 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
Abbott Teams Up With the National Association of Community Health Centers to Expand Access to Nutritious Food and Improve Health
08:05am, Thursday, 20'th Jun 2024
Eight health centers across the U.S. participate in Innovation Incubator to find new ways to integrate healthy food into clinical care Now in its second year, the goal of the Innovation Incubator is t
Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
05:15am, Thursday, 20'th Jun 2024
Dividend stocks offer you a big advantage: regular income no matter what the market is doing. It's a great idea to choose stocks that have a long track record of dividend strength.
Abbott (ABT) Stock Slides as Market Rises: Facts to Know Before You Trade
07:05pm, Monday, 17'th Jun 2024
Abbott (ABT) concluded the recent trading session at $103.45, signifying a -0.22% move from its prior day's close.
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock
10:00am, Monday, 17'th Jun 2024
Abbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Forget The S&P 500 - Here Are 3 Low-Risk, High-Quality Dividend Bargains I Like
07:30am, Monday, 17'th Jun 2024
The S&P 500 has seen impressive returns, largely driven by a few tech giants, raising concerns about diversification risks for investors. Investing in high-quality, anti-cyclical stocks can offer bala
Abbott Declares 402nd Consecutive Quarterly Dividend
12:01pm, Friday, 14'th Jun 2024
ABBOTT PARK, Ill., June 14, 2024 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 55 cents per share.
Abbott's (ABT) AVEIR DR Leadless Pacemaker System Gains CE Mark
10:45am, Wednesday, 12'th Jun 2024
Abbott (ABT) receives a CE mark for AVEIR DR, the world's first dual chamber leadless pacemaker system.
Abbott (ABT) Gets FDA Nod for Two Glucose Monitoring Systems
10:35am, Wednesday, 12'th Jun 2024
Abbott's (ABT) glucose monitoring systems - Lingo and Libre Rio - based on Freestyle Libre technology, receive FDA clearance.
2 Healthcare Stocks to Buy Hand Over Fist in June
07:45am, Wednesday, 12'th Jun 2024
Vertex Pharmaceuticals and Abbott Laboratories are innovative healthcare leaders. Both companies have robust businesses and excellent potential opportunities.
Abbott (ABT) Stock Sinks As Market Gains: Here's Why
06:56pm, Tuesday, 11'th Jun 2024
Abbott (ABT) closed the most recent trading day at $105.81, moving -1.56% from the previous trading session.
2 Magnificent Dividend Growth Stocks to Buy Now
09:45am, Tuesday, 11'th Jun 2024
Dividend growth stocks are superb wealth-creation vehicles. These two blue chips are among the best in the category.
FDA approves two new Abbott over-the-counter continuous glucose monitors
09:31am, Monday, 10'th Jun 2024
Abbott on Monday announced it has received FDA clearance for two new CGMs that will be available without a prescription. A CGM is a small sensor that pokes through the skin and tracks a person's gluco
US FDA clears Abbott's continuous glucose monitors for over-the-counter use
08:21am, Monday, 10'th Jun 2024
Abbott said on Monday that the U.S. Food and Drug Administration has cleared its two continuous glucose monitoring systems for over-the-counter use.
